Clinical Trials Browser

Phase 1/2 × Recurrence × Therapeutics × Clear all

NCT07542717 2026-04-21

ASCERV Study: MRG003 Combined With QL1706 in Recurrent or Metastatic Cervical Cancer

Phase 1/2 Not yet recruiting

Uterine Cervical Neoplasms, Recurrence